Lip Cancer Statistics 2026: Cases, Sun Exposure and SPF Lip Protection

The latest U.S. lip cancer statistics put the age-adjusted rate at 0.5 new cases per 100,000 people each year, using diagnoses from 2019 through 2023. No verified lip-only count exists for 2026. The latest global lip-only estimate is 32,200 modeled new cases in 2022, not a direct tally from every country. [1] [2]

Here, 2026 is the publication year. The figures come from several earlier periods. The American Cancer Society projects 60,480 U.S. cases of oral cavity and pharyngeal cancers in 2026, but that number combines several sites and is not a lip cancer total. [4]

Key Takeaways: Lip Cancer Statistics and SPF Protection

• The newest U.S. lip-only data report 0.5 new cases per 100,000 people per year for 2019–2023, a death rate of 0.02 per 100,000 for 2020–2024, and 90.3% five-year relative survival for 2016–2022. [1]

• The best current global lip-only figure is an estimated 32,200 new cases in 2022, modeled from GLOBOCAN totals and cancer-registry subsite proportions across 185 countries. [2]

• Long-term natural or artificial sunlight exposure is a recognized risk factor for lip and oral cavity cancer, and the AAD recommends broad-spectrum SPF 30 or higher for lips, but neither that guidance nor observational research proves an SPF lip product prevents cancer. [6] [8] [9]

• For readers who want a dedicated daytime lip step, Sky & Sol's tallow lip balm collection includes a lip-specific SPF option. The product label still needs comparison with the AAD's SPF 30+ lip guidance, and no lip product should be framed as preventing cancer. [8] [10]

Lip Cancer Statistics at a Glance

The newest U.S. lip-only data report 0.5 new cases and 0.02 deaths per 100,000 people per year, and the best current global lip-only estimate is 32,200 modeled cases in 2022. [1] [2]

Infographic: Branded infographic showing U.S. lip cancer incidence, mortality, survival, age, and trend data plus the 2022 modeled global estimate.

The table mixes rates, percentages, ages, trends, and modeled counts from different periods. None of them can be added together to produce a single 2026 lip cancer count.

Incidence, mortality, relative survival, and modeled estimates measure different outcomes. Incidence tracks new diagnoses in a population over time, and a death rate tracks deaths. Relative survival compares people with cancer with similar people who do not have it. Modeled estimates fill gaps with statistical methods. A rate, a recorded cohort, and a modeled count answer different questions.

What Counts as Lip Cancer in the Data

Lip cancer can be counted as its own cancer site, but many major datasets do not separate it. The global subsite study uses ICD-10 C00 for the lip and keeps that code apart from oral cavity sites C02 through C06 and from pharyngeal subsites. [2]

SEER reports a lip-specific site. Broader oral cavity and pharyngeal categories may include the tongue, gums, floor of mouth, tonsils, oropharynx, and other areas. Their larger totals cannot answer a lip-only question.

Site coding determines what a number can support. Even an authoritative source is a poor fit for a lip-only statistic when its published category combines several anatomical sites. Use the larger category only as context, name what it includes and never calculate a lip share without a validated subsite method from the source.

Lip-Only Data Versus Oral and Pharyngeal Data

A lip-only measure needs another lip-only measure for a clean comparison. The American Cancer Society's projected 60,480 U.S. cases for 2026 cover oral cavity and pharyngeal cancers together, not the lip alone. [4]

The global numbers require the same care. IARC's current GLOBOCAN 2024 fact sheet reports 452,205 cases for the combined lip and oral cavity category. The separate 32,200 figure comes from a 2022 subsite model that isolated the lip. [2] [3] Neither combined total belongs in a lip-only headline, table or infographic.

Observed Cases, Estimates and Projections

Observed cases are registry records, modeled estimates use statistical methods to fill geographic or subsite gaps, and projections forecast current or future burden from earlier data. These labels are not interchangeable.

A SEER-17 analysis identified 8,625 observed cases of cutaneous squamous cell carcinoma of the lip from 2000 through 2019, covering one histology across 20 years. It is not an annual U.S. count of every lip cancer. [5] The 32,200 global figure is modeled. The ACS 2026 oral cavity and pharynx figure is a combined projection. [2] [4]

U.S. Lip Cancer Incidence, Mortality and Survival

Current U.S. SEER data report 0.5 new lip cancer cases and 0.02 deaths per 100,000 people per year, with 90.3% five-year relative survival. SEER uses separate datasets and periods for incidence, mortality, and survival, so each measure needs its own date label. [1]

Current Incidence and Trend

The U.S. age-adjusted lip cancer incidence rate was 0.5 new cases per 100,000 people per year for 2019–2023, and SEER modeled an average annual rise of 1.1% during 2014–2023. That historical trend is not a projection for 2026. [1]

Age adjustment helps compare populations with different age structures. It does not mean every age group has the same rate. Multiplying the 0.5 rate by today's population would create an unsupported count without the underlying age-specific data.

The lifetime figure is about 0.1%, based on 2021–2023 data. That is a population estimate. It cannot tell one person whether they will receive a lip cancer diagnosis. [1]

Mortality and Survival by Stage

The U.S. age-adjusted lip cancer death rate was 0.02 per 100,000 people per year for 2020–2024, and five-year relative survival was 90.3% for people diagnosed during 2016–2022. Relative survival compares people with lip cancer with similar people in the general population. [1]

SEER reports that 67.4% of lip cancers were localized when diagnosed, with 94.9% five-year relative survival. Regional disease made up 12% of cases with 62.8% survival. Distant disease accounted for 1% of cases with 45.1% survival. Unknown stage accounted for 19% of cases with 93.4% survival. [1] These group estimates cannot forecast one person's outcome.

Read the unknown-stage figure carefully. Its 93.4% survival rate does not make an unknown stage medically favorable. The number describes the recorded group and may reflect documentation, case mix, and available information. Prognosis and treatment depend on the person's diagnosis, stage, overall health, and care.

Who Is Most Affected by Lip Cancer

SEER data show that lip cancer is diagnosed most often at ages 65–74 and that the age-adjusted incidence rate is higher in males than females. These registry patterns are descriptive. They cannot show that age, sex, race, or ethnicity caused a cancer or explain every gap between groups. [1]

Age and Sex Patterns

Lip cancer was diagnosed most often at ages 65–74, and the median age at diagnosis was 70. Adults aged 65–74 made up 29.3% of diagnoses in 2019–2023. [1]

The overall age-adjusted incidence rate was 0.7 per 100,000 for males and 0.3 for females in 2019–2023. Median age at death was 78, and the largest share of deaths, 32.2%, occurred among people aged 85 or older during 2020–2024. [1]

Race and Ethnicity Data

The highest displayed sex-specific incidence rates were 1.0 per 100,000 for non-Hispanic White males and 0.4 for non-Hispanic White females in 2019–2023. Several death-rate cells and the American Indian or Alaska Native incidence cells were not shown because fewer than 16 cases were available. [1]

Small counts produce unstable rates. Registry categories can miss many differences in exposure, diagnosis, and access to care. These figures work better as surveillance signals than as a simple ranking of groups.

A suppressed cell is not zero. It means SEER withheld the rate because the available case count fell below its reporting threshold. This matters most when comparing less populous groups, where a missing value can reflect limited data rather than no disease.

Global Lip Cancer Statistics and Data Limits

The best current global lip-only estimate is 32,200 modeled new cases in 2022, but no current authoritative global total for lip-only mortality or prevalence was found in the reviewed sources. It represented 4.2% of an estimated 758,000 lip, oral cavity, and pharyngeal cancer cases in the IARC subsite study. [2]

The 2022 Modeled Global Case Estimate

The 32,200 figure is a model, not a direct worldwide count. The method used registry subsite proportions from 87 countries and regional proportions for 98 countries without corresponding local data. Together, those inputs produced estimates for 185 countries. [2]

Registry coverage is uneven. The source reports much stronger coverage in North America than in Africa, Central America, South America, and the Caribbean, adding uncertainty to regional estimates. [2] The figure is useful for scale as long as it stays labeled “estimated” or “modeled.”

That method explains how a lip-only incidence estimate can coexist with the standard GLOBOCAN fact sheet, which still groups the lip and oral cavity. First, detailed registries supplied the share assigned to each subsite. Those shares were then applied to broader national estimates. The result is a reasoned model, not evidence that all 32,200 cases were individually counted in one worldwide registry.

Why Lip-Only Mortality and Prevalence Are Missing

No current authoritative global total for lip-only mortality or prevalence was found in the reviewed sources. IARC publishes mortality and five-year prevalence for the combined lip and oral cavity category, but those C00–C06 figures cannot be assigned to the lip alone. [3]

This gap should stay visible. Incidence, deaths, and prevalence answer different questions, and filling a missing lip-only field with a combined oral-cavity number would claim more than the source supports.

Sun Exposure and Other Risk Factors

Long-term exposure to natural sunlight or artificial sunlight, including tanning beds, is a recognized risk factor for lip and oral cavity cancer. NCI lists tobacco use, heavy alcohol use, and male sex. A risk factor does not mean a person will develop cancer. [6]

What the UV Evidence Shows

A 1996 population-based case-control study found substantially higher lip cancer odds among women in the highest lifetime solar-exposure group than among women in the lowest group. The study included 74 women with lip cancer and 105 controls in Los Angeles County. The odds ratio was 13.5, with a 95% confidence interval of 4.5 to 40.6. For the highest category of time outdoors, the odds ratio was 4.7, with a 95% confidence interval of 1.9 to 12.1. [7]

These figures show associations from a small observational study. They are not absolute-risk estimates. The wide confidence intervals signal uncertainty, and results from women diagnosed between 1978 and 1985 cannot prove what caused one person's cancer.

Tobacco, Alcohol and Other Factors

NCI lists tobacco, heavy alcohol use, long-term sunlight exposure, and male sex as risk factors for lip and oral cavity cancer. [6] The reviewed lip-specific sources do not measure these factors on one comparable scale, so a precise causal ranking would mislead readers.

HPV patterns in oropharyngeal cancer do not automatically apply to the lip. Without lip-specific evidence, the sound conclusion is that several factors are documented and no single characteristic or exposure determines an individual's risk.

What Evidence Says About SPF Lip Protection

The American Academy of Dermatology recommends a lip balm with broad-spectrum SPF 30 or higher. [8] This is practical sun-safety guidance. It does not prove that an SPF lip product prevents lip cancer.

SPF Level and Reapplication Guidance

Choose a product labeled for lip use, then follow its directions to apply SPF lip balm and reapply it. An ordinary facial sunscreen is not automatically intended for the lips. The AAD's lip-specific benchmark is broad-spectrum SPF 30+. [8]

SPF is only one part of day-to-day use. Lip products can wear away during eating, drinking, wiping, and other routine contact. Follow the label when reapplying, and add shade or other practical protection during longer periods outdoors.

For a practical routine, Sky & Sol's guide shows how to reapply lip SPF through a typical day. Follow the product label after eating, drinking, or wiping the lips.

What Lip-Protection Research Can and Cannot Prove

The 1996 Los Angeles County study found lower odds of lip cancer among highly sun-exposed women who used lip protection more than once a day than among women who used it once a day or less. Infrequent users had an odds ratio of 7.3. More frequent users had an odds ratio of 3.2. The confidence intervals were 1.9–27.2 and 1.1–9.2. [7] The pattern suggests an association, but it cannot establish that lip protection caused the difference.

An NCI evidence review found inconsistent benefit for sunscreen in preventing squamous cell carcinoma and inadequate evidence to measure the size of any effect. The review was not specific to lip cancer. [9] SPF still has a place in a broader sun-protection routine, alongside shade and other protective behavior, but it does not eliminate risk.

Where Sky & Sol Fits and Where It Does Not

Sky & Sol's role in this decision is limited to a lip-specific product option. Its current Lip Jelly is made for the lips and labeled SPF 25 with 15% zinc oxide. [10] For readers who want moisture and labeled SPF in one daytime step, that format avoids carrying a separate non-SPF balm. Application and reapplication still need to follow the product label.

Compare that label with independent guidance before choosing it. SPF 25 is below the AAD's broad-spectrum SPF 30+ recommendation for lips. [8] The product page states that broad-spectrum performance was third-party tested, but the underlying report was not available during review. This article does not treat that claim as independently verified. Lip Jelly should not be described as preventing, treating or reducing lip cancer.

When Lip Changes Need Professional Evaluation

Persistent or concerning lip changes need assessment by a qualified healthcare professional or dentist. NCI lists possible signs of lip and oral cavity cancer that include a sore that does not go away, a lump or thickening, a red or white patch, bleeding, pain, and numbness. [6]

Many of these changes have causes other than cancer, and appearance alone cannot provide a diagnosis. Individualized advice is more useful than trying to interpret a statistic or diagnose a lesion at home.

No single look reliably separates cancer from irritation, injury, infection, or another condition at home. Duration and change over time matter, as does a clinical examination. A dentist or healthcare professional can decide whether monitoring, testing or referral makes sense.

FAQs About Lip Cancer Statistics

Lip cancer is rare in U.S. data, worldwide totals are modeled, and SPF guidance cannot promise cancer prevention.

How Common Is Lip Cancer in the United States?

The age-adjusted U.S. incidence rate was 0.5 new cases per 100,000 people per year, based on SEER diagnoses from 2019–2023. [1] The rate should not be converted into an unsupported national case count.

Is Lip Cancer Becoming More Common?

SEER modeled an average annual incidence increase of 1.1% during 2014–2023, and death rates were stable during 2015–2024. These are past trends, not projections of 2026 cases. [1]

Is Lip Cancer the Same as Oral Cancer?

No. Lip cancer is ICD-10 C00. Combined datasets may group the lip with oral cavity sites C00–C06 or with oral and pharyngeal sites. [2] A combined count should never be reported as a lip-only statistic.

How Many Lip Cancer Cases Occur Worldwide?

The best current lip-only figure is an estimated 32,200 new cases in 2022. Researchers modeled the total from registry subsite proportions and GLOBOCAN data across 185 countries, so it is not a directly observed worldwide count or a 2026 figure. [2]

Can Sun Exposure Cause Lip Cancer?

Long-term natural or artificial sunlight exposure is a recognized risk factor, and a population-based case-control study found a strong association with lip cancer. [6] [7] A risk factor raises probability at the population level, but it does not prove the cause of an individual case. Tobacco and heavy alcohol use are other recognized risk factors. [6]

Does SPF Lip Balm Prevent Lip Cancer?

Direct evidence is not strong enough to promise that SPF lip balm prevents lip cancer or eliminates risk. An older observational study suggested an association between more frequent lip protection and lower risk among highly exposed women, but it did not establish causation. [7] The AAD still recommends broad-spectrum SPF 30+ for lips as part of sun protection. [8]

What SPF Should I Use on My Lips?

The AAD recommends broad-spectrum SPF 30 or higher for the lips. [8] Choose a product labeled for lip use and follow its reapplication directions. Sky & Sol's current Lip Jelly is labeled SPF 25, which is below that threshold. [10]

When Should I See a Healthcare Professional?

Consult a qualified healthcare professional or dentist about a persistent sore, lump, thickening, red or white patch, bleeding, pain, or numbness. [6] These signs do not confirm cancer, but they warrant professional evaluation.

What the Numbers Mean for Lip Sun Safety

Lip cancer is rare in U.S. population data, but age, sex, stage, and long-term exposure patterns still matter. Use the evidence to make two practical decisions. Choose a product labeled for lip use that matches professional SPF guidance, and ask a qualified healthcare professional or dentist about persistent changes. Readers considering Sky & Sol can compare its SPF 25 Lip Jelly with the AAD's SPF 30+ lip recommendation before deciding whether it fits their daytime routine.

For broader context on everyday protection habits, Sky & Sol's sunscreen use statistics guide compares routine behavior with public-health data. Lip cancer statistics describe groups, not one person's future. And no sunscreen or lip product removes all risk.

References

1. National Cancer Institute. “SEER Cancer Stat Facts: Lip Cancer.” Surveillance, Epidemiology, and End Results Program, 2026, https://seer.cancer.gov/statfacts/html/lip.html. Accessed 12 Nov. 2026.

2. Rumgay, Harriet, et al. “Global Incidence of Lip, Oral Cavity, and Pharyngeal Cancers by Subsite in 2022.” CA: A Cancer Journal for Clinicians, vol. 76, no. 1, 2026, article e70048, doi:10.3322/caac.70048, https://pmc.ncbi.nlm.nih.gov/articles/PMC12674102/.

3. International Agency for Research on Cancer. “Lip, Oral Cavity Fact Sheet.” Global Cancer Observatory, GLOBOCAN 2024, version 1.0, 2026, https://gco.iarc.who.int/media/globocan/factsheets/cancers/1-lip-oral-cavity-fact-sheet.pdf. Accessed 12 Nov. 2026.

4. American Cancer Society. Cancer Facts & Figures 2026. American Cancer Society, 2026, https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2026/2026-cancer-facts-and-figures.pdf.

5. Zhang, Jin, et al. “Trends in Cutaneous Squamous Cell Carcinoma on the Lip Incidence and Mortality in the United States, 2000–2019.” Frontiers in Oncology, vol. 13, 2023, article 1111907, doi:10.3389/fonc.2023.1111907, https://pmc.ncbi.nlm.nih.gov/articles/PMC10149798/.

6. National Cancer Institute. “Lip and Oral Cavity Cancer Treatment, Patient Version.” National Cancer Institute, https://www.cancer.gov/types/head-and-neck/patient/adult/lip-mouth-treatment-pdq. Accessed 12 Nov. 2026.

7. Pogoda, Janice M., and Susan Preston-Martin. “Solar Radiation, Lip Protection, and Lip Cancer Risk in Los Angeles County Women.” Cancer Causes & Control, vol. 7, no. 4, 1996, pp. 458–463, doi:10.1007/BF00052672, https://pubmed.ncbi.nlm.nih.gov/8813434/.

8. American Academy of Dermatology. “How Do I Know If I'm Using the Right Sunscreen?” American Academy of Dermatology, https://www.aad.org/public/everyday-care/sun-protection/shade-clothing-sunscreen/choosing-right-sunscreen. Accessed 12 Nov. 2026.

9. National Cancer Institute. “Skin Cancer Prevention (PDQ), Health Professional Version.” National Cancer Institute, https://www.cancer.gov/types/skin/hp/skin-prevention-pdq. Accessed 12 Nov. 2026.

10. Sky & Sol. “Sky and Sol Lip Jelly SPF 25.” Sky & Sol, https://skyandsol.co/products/sky-and-sol-lip-jelly-spf25. Accessed 12 Nov. 2026.

Sources Index

U.S. lip-only data: [1]

Global incidence: [2]

Dataset limits: [2], [3], [4], [5]

Risk factors and signs: [6]

SPF guidance: [8], [9]

Observational studies: [7]

Brand proof: [10]